Drug Profile
Research programme: G protein-coupled receptor modulators - Pfizer/Taisho Pharmaceutical
Alternative Names: ATC 0021; ATC 0044; ATC 0065; ATC 0175 (AR 224349); ATC 0453; ATC 0759; GPCR modulators - Pfizer/TaishoLatest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Arena Pharmaceuticals
- Class Cyclohexylamines; Quinazolines; Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder; Obesity; Sleep disorders
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 07 May 2008 A lead compound from this programme has entered clinical development
- 07 Nov 2007 Pharmacodynamics data from Preclinical trials in Anxiety and Depression presented at the 37th Annual Meeting of the Society for Neuroscience (SFN-2007)